Fujifulm’s Aspire Cristalle digital mammography solution received FDA clearance yesterday and includes features promoting patient comfort and image quality.
Aspire Cristalle, a new digital mammography breast imaging solution with innovative and methodical features, by Fujifilm, received U.S. Food and Drug Administration (FDA) 510(k) clearance yesterday.
The Aspire Cristalle uses novel detector engineering called hexagonal close pattern (HCP), a detector pixel design engineered to deliver higher acquisition efficiency, finer detail, higher DQE, higher MTF and lower dose than conventional square pixel arrays, according to a release. “[The design is] engineered to produce brilliant images at low dose,” the release stated.
Fujifilm’s image processing, iAEC automated exposure controls and ISC precisely tuned contrast, also enhances the image quality, according to the release. The processing adapts to the specific characteristics for every breast type and implants, the release said.
Patient comfort was also considered in the new mammography solution. Fujifilm included their patented “Comfort Paddle,” in the Aspire Cristalle, which is designed to ease the discomfort of mammograms, the release said. The paddle boasts soft edges, flexible composition and a 4-way pivot contours to the individual shape of the breast for a more
[[{"type":"media","view_mode":"media_crop","fid":"25470","attributes":{"alt":"Fujifilm Aspire Cristalle","class":"media-image media-image-right","id":"media_crop_1823864043690","media_crop_h":"283","media_crop_image_style":"-1","media_crop_instance":"2326","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"137","media_crop_x":"0","media_crop_y":"0","style":"margin: 1px; border-style: solid; line-height: 1.538em; width: 150px; height: 310px; float: right;","title":" ","typeof":"foaf:Image"}}]]
comfortable application of compression for optimal tissue separation, the release stated. Patient grip handles, padding for added stability and comfort, and soft backlighting and graphic mural decals were incorporated for further patient comfort. The system also allows
improved access for wheelchair exams, the release said.
“Aspire Cristalle nicely represents our latest culmination of imaging innovation and attention to every detail in design,” Rob Fabrizio, director of marketing and product development, digital X-ray and women’s health, FUJIFILM Medical Systems USA, Inc., said in a release. “The Aspire Cristalle will deliver brilliant images with gentle dose, while redefining the patient experience through a notably more comfortable exam.”
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.